Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS Lett ; 518(1-3): 154-8, 2002 May 08.
Article in English | MEDLINE | ID: mdl-11997037

ABSTRACT

Prostaglandin E2 (PGE2)-dependent effects on various cell responses are regulated by respective PGE2 receptors (EP1, EP2, EP3, EP4) expressing in target cells. Alveolar type II cell (a main progenitor cell of lung adenocarcinoma) expressed only EP4, while human lung adenocarcinoma cells (A549) expressed EP3 as well as EP4. An antagonistic effect of EP3 against EP4 through the modulation of cyclic AMP level is required for PGE2-mediated activation of Ras signal pathway in A549 cells. These results suggest that the expression of EP3 may be a critical factor for the PGE2-mediated activation of Ras signal pathway in A549 cells.


Subject(s)
Adenocarcinoma/metabolism , Dinoprostone/pharmacology , Lung Neoplasms/metabolism , Proto-Oncogene Proteins p21(ras)/metabolism , Receptors, Prostaglandin E/metabolism , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Cell Division/drug effects , Cyclic AMP/biosynthesis , Dose-Response Relationship, Drug , Humans , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Pulmonary Alveoli/metabolism , Receptors, Prostaglandin E/genetics , Receptors, Prostaglandin E, EP3 Subtype , Signal Transduction , Tumor Cells, Cultured , Virulence Factors, Bordetella/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...